BioLargo CEO Dennis Calvert joined Proactive's Natalie Stoberman to share more details of the addition of Nicholas Valeriani and Linda Park to the board of directors of subsidiary Clyra Medical Technologies.
BioLargo noted that Valeriani has decades of executive experience in the medical device industry. He spent 34 years at Johnson & Johnson, where he led several corporate functions and was a member of its executive committee.
Park is a trusted executive and legal professional with a proven track record of supporting and advising public companies at the corporate board and executive level at billion-dollar corporations.
Proactive USA
+1 347-449-0879
This email address is being protected from spambots. You need JavaScript enabled to view it.
| Last Trade: | US$0.18 |
| Daily Change: | 0.0029 1.64 |
| Daily Volume: | 175,452 |
| Market Cap: | US$56.590M |
November 03, 2025 October 13, 2025 September 29, 2025 August 13, 2025 July 01, 2025 | |
COPYRIGHT ©2025 GREEN STOCK NEWS